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2. 6 Australia (Dr Donna Mak) 
 
A developed country approach to eliminating blinding trachoma 
 
In Australia trachoma is endemic, only in pockets among aboriginal people. The TF 
prevalence in school-age children in 2002−2003 ranged from 0−27% (district) and 0−60% 
(community).(4)  Trichiasis in indigenous adults in highly disease-endemic communities over 
the age of 40 years is approximately 10%. There are limited data on face-washing, but a 
survey of three schools in 2004 gave rates of 55%. The rate of latrine use and access to water 
is almost universal (96%). 
The challenges for Australia include the fact that, as a federation, Australia has no 
national trachoma control programme, relying on collaboration with state health departments, 
primary health care services, and aboriginal community-controlled health organizations. Each 
state has a different health act, none of which mention trachoma as a notifiable disease. There 
is a currently a lack of consensus among public health and specialist eye health professionals 
regarding the severity and importance of trachoma as a public health issue. Similarly, there is 
no consensus on the best practice in surveillance and control activities. There are several 
trachoma control programmes at district level, only one of which addresses trichiasis. The 
multiplicity of control programmes has produced non-standardized data (and very little data at 
all on trichiasis). Those primarily affected by trachoma are in small numbers, highly 
marginalized and mobile, living in remote, sparsely populated areas. It is estimated that, 
countrywide, fewer than 5000 have active trachoma, and less than 100 have trichiasis. 
Blinding trachoma has a very low profile, and is generally not recognized as existing 
until surveys provide evidence; it cannot compete with life-threatening disease priorities; and 
there is reluctance to have the condition treated. Access may be difficult, given the distances 
involved, and there may be language barriers to treatment. High turnover in health staff is a 
problem in areas where trachoma is endemic, resulting in low awareness and skill levels. 
Cultural practices and norms can mean that rubbish collection, water use and environmental 
cleanliness are poor and behavioural change is difficult, even contentious, given the existence 
of ritual practices associated with water use, for example. The Federal Government or 
Ministry of Health has no mandate to change or implement trachoma control programmes as 
they are state-run programmes. 
 
(4) Unlike in developing countries, in Australian indigenous populations, “community” denotes groups of 
50−100 people, Similarly, in indigenous populations, the population in a “district” may be 10 000. 
 
 
Successes: Trachoma control programmes have been successfully and consistently 
implemented by district health units in four disease-endemic areas of Western Australia and 
one in the Northern territories. Primary health care services, local schools and environment 
health staff have been closely involved. Active trachoma has decreased in the Kimberly 
District from 40% (1976−1979) to 11% in 2002. As prevalence decreases below 5%, schools 
and communities are no longer surveyed, so overall prevalence is less than 11%. National 
funding for health care provision for indigenous people has doubled since 1996, potentially 
leading to better access. 
Opportunities: Australia has a communicable disease network, which in 2004 
recognized trachoma as a public health issue for the first time. Draft national guidelines for 
public health management of trachoma have been drafted and are undergoing consultation. 
This will present an opportunity to create national consensus on best practice, better 
coordination between districts and provinces, and implementation of control programmes in 
all areas where trachoma is known to be endemic with inclusion of trichiasis. An opportunity 
to increase detection of trichiasis is presented by the indigenous health check, in which there 
is now a special item number under the Medicare health insurance scheme. A proposal has 
been made on the creation of a national uniform data set with reporting to the Australian 
Government. 
From a national perspective, for Australia’s 20 million population, blinding trachoma 
is not a public health problem and has virtually been eliminated. However, it is still a problem 





Health status of indigenous peoples: Although it has improved, life expectancy and 
health status for aboriginal people in Australia is still 20 years less than for non-indigenous 
peoples. The infant mortality rate among the indigenous population has plateaued but is still 
much higher than for non-indigenous Australians, Trachoma is not a priority at national level, 
but at district level, where it is endemic, there are some very active control programmes. 
Historically governments have been neglectful of indigenous populations and there is still a 
great deal to be done to balance the equation, reflected in the present health outcomes. 
Laboratory testing for infection: Although the rates of HIV/AIDS are not high, there 
are very high rates of sexually transmitted chlamydia in many areas where trachoma is 
endemic. Genotyping of ocular trachoma isolates has been done, and has verified the 
identification of ocular, not genital types in children. 
In view of the many infectious disease affecting the aboriginal population, mass 
distribution of antibiotics might be seen to be useful, to cure several diseases at once. Mass 
distribution of azithromycin is being done under WHO guidelines as part of the trachoma 
control programmes, although not yet under a national policy. It has not been possible, given 
political, cultural and ethical constraints, to make a mass distribution of antibiotics to adults to 
counter sexually transmitted infections (STI). 
Desegregation of data: It is important in making public health decisions, to look at 
disaggregated data, so as to distinguish where the pockets of disease still exist, and allocate 
priorities according to those. This applies to Australia, and also to other countries. 
Elimination date: No date has yet been announced by the Government of Australia 
for elimination of blinding trachoma. 
 
